SCHEMBL7366500

SCHEMBL7366500

CNC(=O)[C@@H](N)CCC(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 2/20 0.51
TSHR P16473 3/20 0.46
LMNA P02545 3/20 0.39
KDM4E B2RXH2 1/20 0.39
DPP4 P27487 2/20 0.39
DPP8 Q6V1X1 2/20 0.39
DPP9 Q86TI2 2/20 0.39
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CA12 O43570 1/20 0.35
CA14 Q9ULX7 1/20 0.35
GRM8 O00222 1/20 0.34
GRM6 O15303 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GSR P00390 1/20 0.34
CYP1A2 P05177 1/20 0.34
GRIK1 P39086 1/20 0.34
GRM5 P41594 1/20 0.34
GRIA1 P42261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12534381 1.00 SLC1A1 (0.51) SLC1A1TSHRLMNAKDM4EDPP4
Trifluoroacetic Acid SCHEMBL7398921 0.88 SLC1A1 (0.46) SLC1A1TSHRLMNAKDM4EDPP4
SCHEMBL10078349 0.82 SLC1A1 (0.36) SLC1A1LMNADPP4DPP8DPP9
SCHEMBL7403192 0.82 SLC1A1 (0.36) SLC1A1LMNADPP4DPP8DPP9
SCHEMBL7740801 0.82 SLC1A1 (0.36) SLC1A1LMNADPP4DPP8DPP9
SCHEMBL9190278 0.82 SLC1A1 (0.53) SLC1A1TSHRLMNAKDM4EKMT2A
SCHEMBL23085255 0.81 SLC1A1 (0.49) SLC1A1TSHRLMNAKDM4EDPP4
SCHEMBL13972817 0.81 SLC1A1 (0.49) SLC1A1TSHRLMNAKDM4EDPP4
SCHEMBL2723398 0.80 SLC1A1 (0.51) SLC1A1TSHRLMNAKDM4EKMT2A
SCHEMBL13958785 0.79 SLC1A1 (0.47) SLC1A1TSHRLMNAKDM4EDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689538-B1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1998-08-12 EP disclosed
EP-0651738-B1 NATURAL AMINO ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1998-01-14 EP disclosed
US-5700838-A Hydroxamic acid derivatives as metalloproteinase inhibitors BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-12-23 US disclosed
US-5652262-A Hydroxamic acid derivatives as metalloproteinase inhibitors BRITISH BIOTECH PHARMACEUTICAL, LTD. (GB) 1997-07-29 US disclosed
US-5643964-A Natural amino acid derivatives as metalloproteinase inhibitors BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-07-01 US disclosed
EP-0651739-B1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1997-04-09 EP disclosed
EP-0754688-A2 Dioxolane intermediates BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-01-22 EP disclosed
EP-0689538-A1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-01-03 EP disclosed
EP-0651739-A1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS. BRITISH BIOTECH PHARM (GB) 1995-05-10 EP disclosed
EP-0651738-A1 NATURAL AMINO ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-05-10 EP disclosed
WO-1994021625-A1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-09-29 WO disclosed
WO-1994002446-A1 NATURAL AMINO ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-02-03 WO disclosed
WO-1994002447-A1 HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-02-03 WO disclosed